Clinical characteristics and survival outcome of patients with estrogen receptor low positive breast cancer

BACKGROUND: The benefit of endocrine therapy for patients with estrogen receptor (ER)-low (1%–10%) positive breast cancer is a matter for debate. We aimed to compare the clinical characteristics and survival outcome of ER-low patients with ER-high (＞10%) positive patients and ER-negative patients. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Chuanxu, Zhong, Xiaorong, Fan, Yu, Wu, Yanqi, Zheng, Hong, Luo, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920919/
https://www.ncbi.nlm.nih.gov/pubmed/35279509
http://dx.doi.org/10.1016/j.breast.2022.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920919/
https://www.ncbi.nlm.nih.gov/pubmed/35279509
http://dx.doi.org/10.1016/j.breast.2022.03.002

Ejemplares similares